Timeline, Epidemiology, And Risk Factors for Bacterial, Fungal, And Viral Infections in Children and Adolescents after Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 1, 2013, Pages 94-101

  Srinivasan, Ashok ^a,b   Wang, Chong ^a   Srivastava, Deo K ^a   Burnette, Ken ^a   Shenep, Jerry L ^a,b   Leung, Wing ^a,b   Hayden, Randall T ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Allogeneic; Children; Infections; Stem cell transplant

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; COTRIMOXAZOLE; GANCICLOVIR; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; BACTEREMIA; BACTERIAL INFECTION; BLOOD SAMPLING; CANDIDEMIA; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAPLOIDY; HUMAN; INFANT; INFECTION RISK; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; TOXOPLASMOSIS; VIREMIA; VIRUS INFECTION;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; METABOLISM, INBORN ERRORS; MYCOSES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VIRUS DISEASES;

EID: 84871924343     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2012.08.012     Document Type: Article

References (37)

1. Collin B.A., Leather H.L., Wingard J.R., Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001, 33:947-953.
2. Kontoyiannis D.P., Marr K.A., Park B.J., et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis 2010, 50:1091-1100.
3. Boeckh M., Leisenring W., Riddell S.R., et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003, 101:407-414.
4. Ljungman P., Perez-Bercoff L., Jonsson J., et al. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haematologica 2006, 91:78-83.
5. Garcia-Vidal C., Upton A., Kirby K.A., Marr K.A. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008, 47:1041-1050.
6. Ochs L., Shu X.O., Miller J., et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995, 86:3979-3986.
7. Wade J.C., Newton B., Flournoy N., Meyers J.D. Oral acyclovir for prevention of herpes simplex reactivation after marrow transplantation. Ann Intern Med 1984, 100:823-828.
8. Aversa F. Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States. Bone Marrow Transplant 2008, 41:473-481.
9. Flomenberg P., Babbitt J., Drobyski W.R., et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994, 169:775-781.
10. Srinivasan A., Wang C., Yang J., Shenep J.L., Leung W.H., Hayden R.T. Symptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011, 17:1520-1527.
11. Hale G.A., Heslop H.E., Krance R.A., et al. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 1999, 23:277-282.
12. Gu Z., Belzer S.W., Gibson C.S., Bankowski M.J., Hayden R.T. Multiplexed, real-time PCR for quantitative detection of human adenovirus. J Clin Microbiol 2003, 41:4636-4641.
13. De Pauw B., Walsh T.J., Donnelly J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
14. Leung W.H., Turner V., Richardson S.L., et al. Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors. Hum Immunol 2001, 62:399-407.
15. Leung W., Campana D., Yang J., et al. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood 2011, 118:223-230.
16. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995, 15:825-828.
17. Ljungman P., Engelhard D., De La Cámara R., et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Disease Working Party of the EBMT. Bone Marrow Transplant 2005, 35:737-746.
18. Fine J.P., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
19. Kalbfleisch J.D., Prentice R.L. The statistical analysis of failure data 1980, John Wiley, New York, pp 163-188.
20. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1141-1154.
21. Mikulska M., Del Bono V., Raiola A.M., et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 2009, 15:47-53.
22. Poutsiaka D.D., Munson D., Price L.L., Chan G.W., Snydman D.R. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant 2011, 46:300-307.
23. Atkinson K., Storb R., Prentice R.L., et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979, 53:720-731.
24. Eapen M., Logan B.R., Confer D.L., et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant 2007, 13:1461-1468.
25. Almyroudis N.G., Fuller A., Jakubowski A., et al. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 2005, 7:11-17.
26. Neofytos D., Horn D., Anaissie E., et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (PATH) alliance registry. Clin Infect Dis 2009, 48:265-273.
27. Kontoyiannis D.P., Marr K.A., Park B.J., et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant-associated infection surveillance network (TRANSNET) database. Clin Infect Dis 2010, 50:1091-1100.
28. Marr K.A., Carter R.A., Boeckh M., Martin P., Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002, 100:4358-4366.
29. Baddley J.W., Stroud T.P., Salzman D., Pappas P.G. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis 2001, 32:1319-1324.
30. Lewin S.R., Heller G., Zhang L., et al. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood 2002, 100:2235-2242.
31. Clave E., Rocha V., Talvensaari K., et al. Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood 2005, 105:2608-2613.
32. Schönberger S., Meisel R., Adams O., et al. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010, 16:1428-1435.
33. Nichols W.G., Corey L., Gooley T., Davis C., Boeckh M. High risk of death due to bacterial and fungal infections among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 2002, 185:273-282.
34. Cantoni N., Hirsch H.H., Khanna N., et al. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant 2010, 16:1309-1314.
35. Aversa F., Terenzi A., Tabilio A., et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005, 23:3447-3454.
36. Chen X., Hale G.A., Barfield R., et al. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol 2006, 135:524-532.
37. Bjorklund A., Aschan J., Labopin M., et al. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation. Bone Marrow Transplant 2007, 40:1055-1062.